160 related articles for article (PubMed ID: 36642294)
1. The Risk of Developing Long COVID in Patients With Inflammatory Bowel Diseases: Do Immunosuppressive Drugs Matter?
Bourgonje AR; Otten AT
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1971-1972. PubMed ID: 36642294
[No Abstract] [Full Text] [Related]
2. Incidence of Long COVID and Impact of Medications on the Risk of Developing Long COVID in a Nationwide Cohort of IBD Patients.
Khan N; Mahmud N; Patel M; Sundararajan R; Reinisch W
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1960-1962.e1. PubMed ID: 36566815
[No Abstract] [Full Text] [Related]
3. Turkish IBD Organization's Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic.
Törüner M; Kalkan İH; Akyüz F; Tezel A; Çelik AF
Turk J Gastroenterol; 2021 Jun; 32(6):488-492. PubMed ID: 34405814
[TBL] [Abstract][Full Text] [Related]
4. [Viral Hepatitis in Patients with Inflammatory Bowel Disease].
Shin SH; Park SH
Korean J Gastroenterol; 2022 Aug; 80(2):51-59. PubMed ID: 36004631
[TBL] [Abstract][Full Text] [Related]
5. Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease.
Alexander JL; Selinger CP; Powell N;
Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):987-988. PubMed ID: 34653395
[No Abstract] [Full Text] [Related]
6. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion.
Sarzi-Puttini P; Marotto D; Antivalle M; Salaffi F; Atzeni F; Maconi G; Monteleone G; Rizzardini G; Antinori S; Galli M; Ardizzone S
Autoimmun Rev; 2020 Jul; 19(7):102574. PubMed ID: 32376399
[TBL] [Abstract][Full Text] [Related]
7. Uneventful Course in Patients With Inflammatory Bowel Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak in Northern Italy.
Norsa L; Indriolo A; Sansotta N; Cosimo P; Greco S; D'Antiga L
Gastroenterology; 2020 Jul; 159(1):371-372. PubMed ID: 32247695
[No Abstract] [Full Text] [Related]
8. Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases.
Burke KE; Kochar B; Allegretti JR; Winter RW; Lochhead P; Khalili H; Colizzo FP; Hamilton MJ; Chan WW; Ananthakrishnan AN
Inflamm Bowel Dis; 2021 Jan; 27(2):155-161. PubMed ID: 33089863
[TBL] [Abstract][Full Text] [Related]
9. Coordinating preventive medicine in patients with inflammatory bowel disease: whose responsibility is it anyway?
Gutierrez A
Clin Gastroenterol Hepatol; 2009 May; 7(5):500-1. PubMed ID: 19245851
[No Abstract] [Full Text] [Related]
10. Safety of Drugs During Previous and Current Coronavirus Pandemics: Lessons for Inflammatory Bowel Disease.
Sebastian S; Gonzalez HA; Peyrin-Biroulet L
J Crohns Colitis; 2020 Nov; 14(11):1632-1643. PubMed ID: 32520312
[TBL] [Abstract][Full Text] [Related]
11. Challenges in paediatric inflammatory bowel diseases in the COVID-19 time.
Dipasquale V; Cucchiara S; Martinelli M; Miele E; Aloi M; Romano C
Dig Liver Dis; 2020 May; 52(5):593-594. PubMed ID: 32276846
[No Abstract] [Full Text] [Related]
12. SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy.
Selim R; Wellens J; Marlow L; Satsangi JJ
Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):989. PubMed ID: 34655528
[No Abstract] [Full Text] [Related]
13. Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment.
Aithal GP; Mansfield JC
Aliment Pharmacol Ther; 2001 Aug; 15(8):1101-8. PubMed ID: 11472312
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppression, IBD, and risk of lymphoma.
Bebb JR; Aithal GP; Logan RP
Gut; 2002 Aug; 51(2):296. PubMed ID: 12117900
[No Abstract] [Full Text] [Related]
15. Risk of nonmelanoma skin cancer in patients with inflammatory bowel disease who use thiopurines is not increased.
van Schaik FD; van Oijen MG; Smeets HM; van der Heijden GJ; Siersema PD; Oldenburg B
Clin Gastroenterol Hepatol; 2011 May; 9(5):449-50.e1; author reply 450-1. PubMed ID: 21296187
[No Abstract] [Full Text] [Related]
16. [Benefits and risks of immunosuppression in chronic inflammatory bowel diseases].
Rogler G
Dtsch Med Wochenschr; 2008 Sep; 133(38):1917-21. PubMed ID: 18785084
[No Abstract] [Full Text] [Related]
17. COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020).
Marín-Jiménez I; Zabana Y; Rodríguez-Lago I; Marín L; Barreiro-de Acosta M; Esteve M;
Gastroenterol Hepatol; 2020; 43(7):408-413. PubMed ID: 32419715
[TBL] [Abstract][Full Text] [Related]
18. Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic.
Melmed GY; Rubin DT; McGovern DPB
Gastroenterology; 2021 Feb; 160(3):639-644. PubMed ID: 33065064
[No Abstract] [Full Text] [Related]
19. How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician.
Chebli JMF; Queiroz NSF; Damião AOMC; Chebli LA; Costa MHM; Parra RS
World J Gastroenterol; 2021 Mar; 27(11):1022-1042. PubMed ID: 33776370
[TBL] [Abstract][Full Text] [Related]
20. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.
Kucharzik T; Ellul P; Greuter T; Rahier JF; Verstockt B; Abreu C; Albuquerque A; Allocca M; Esteve M; Farraye FA; Gordon H; Karmiris K; Kopylov U; Kirchgesner J; MacMahon E; Magro F; Maaser C; de Ridder L; Taxonera C; Toruner M; Tremblay L; Scharl M; Viget N; Zabana Y; Vavricka S
J Crohns Colitis; 2021 Jun; 15(6):879-913. PubMed ID: 33730753
[No Abstract] [Full Text] [Related]
[Next] [New Search]
